Approval · Notice of Compliance 13801 · 2012
CLINDASOL: Notice of Compliance 13801
Issued August 24, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13801
- Date
- August 24, 2012
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph and labels
- Therapeutic class
- Acne therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLINDASOL | Not yet assigned | — |
Medicinal ingredients
- AVOBENZONE 22 MG per G
- OCTINOXATE 75 MG per G
- CLINDAMYCIN PHOSPHATE 13.4 MG per G